×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IMRX – immuneering corporation - class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IMRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/24
08:09 am
imrx
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $13.00 price target on the stock.
Medium
Report
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $13.00 price target on the stock.
3/21
04:30 pm
imrx
Immuneering Corporation Announces Grant of Inducement Award
Medium
Report
Immuneering Corporation Announces Grant of Inducement Award
3/21
09:05 am
imrx
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
High
Report
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
3/20
05:05 pm
imrx
Immuneering GAAP EPS of -$0.58 [Seeking Alpha]
High
Report
Immuneering GAAP EPS of -$0.58 [Seeking Alpha]
3/20
04:05 pm
imrx
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Medium
Report
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
3/20
07:00 am
imrx
Immuneering Names Dr. Igor Matushansky as Chief Medical Officer
Low
Report
Immuneering Names Dr. Igor Matushansky as Chief Medical Officer
2/6
01:31 pm
imrx
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Low
Report
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
2/6
08:11 am
imrx
Immuneering Announces Clinical Supply Agreement with Regeneron Pharmaceuticals to Evaluate IMM-1-104 in Combination with Libtayo® (cemiplimab) [Yahoo! Finance]
Low
Report
Immuneering Announces Clinical Supply Agreement with Regeneron Pharmaceuticals to Evaluate IMM-1-104 in Combination with Libtayo® (cemiplimab) [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
3/20/2025
04:05 pm
imrx
immuneering corporation - class a
MISS
Report
9.1%
immuneering corporation - class a
11/13/2024
04:05 pm
imrx
immuneering corporation - class a
BEAT
Report
12.1%
immuneering corporation - class a
8/6/2024
04:05 pm
imrx
immuneering corporation - class a
BEAT
Report
-8.1%
immuneering corporation - class a
5/7/2024
04:05 pm
imrx
immuneering corporation - class a
MISS
Report
4.5%
immuneering corporation - class a
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/24
04:12 pm
imrx
Form 4 Immuneering Corp For: Mar 21 Filed by: Matushansky Igor
Medium
Report
Form 4 Immuneering Corp For: Mar 21 Filed by: Matushansky Igor
3/24
04:05 pm
imrx
Form 3 Immuneering Corp For: Mar 17 Filed by: Matushansky Igor
Low
Report
Form 3 Immuneering Corp For: Mar 17 Filed by: Matushansky Igor
3/20
04:48 pm
imrx
Form 10-K Immuneering Corp For: Dec 31
Medium
Report
Form 10-K Immuneering Corp For: Dec 31
3/20
04:07 pm
imrx
Form 8-K Immuneering Corp For: Mar 20
Medium
Report
Form 8-K Immuneering Corp For: Mar 20
2/7
04:25 pm
imrx
Form 4 Immuneering Corp For: Feb 05 Filed by: Morales Mallory
Low
Report
Form 4 Immuneering Corp For: Feb 05 Filed by: Morales Mallory
2/7
04:22 pm
imrx
Form 4 Immuneering Corp For: Feb 05 Filed by: Neufeld Leah R
Low
Report
Form 4 Immuneering Corp For: Feb 05 Filed by: Neufeld Leah R
2/7
04:18 pm
imrx
Form 4 Immuneering Corp For: Feb 05 Filed by: Brakewood Harold Eugene
Low
Report
Form 4 Immuneering Corp For: Feb 05 Filed by: Brakewood Harold Eugene
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: